One of the assets that Lantheus has taken was LRRC15 antibody for osteosarcoma (aggressive bone cancer).
It has both ODD and RPDD from the FDA.
I hope we don't regret selling it cheap.
Ann: Radiopharm Receives Strategic Investment for up to A$18 mill, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.5¢ | $70.43K | 1.973M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 647890 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.7¢ | 300000 | 1 |
View Market Depth
| Last trade - 15.28pm 26/07/2024 (20 minute delay) ? |
| RAD (ASX) Chart |